{
    "title": "Acorda reports five deaths in Parkinson's trial, shares plunge",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-5085149/Acorda-halts-enrollment-Parkinsons-trial-shares-plunge.html",
    "date": "2017-11-15",
    "keywords": [
        "drug",
        "drugmaker",
        "acorda",
        "tozadenant",
        "company",
        "latestage",
        "trial",
        "quarter",
        "divya",
        "grover",
        "percent",
        "success",
        "ampyra",
        "safety",
        "sepsis",
        "blood",
        "analyst",
        "wednesday",
        "inc",
        "series",
        "loss",
        "exclusivity",
        "flagship",
        "sclerosis",
        "infection",
        "mid",
        "agranulocytosis",
        "absence",
        "view",
        "potential",
        "byproduct",
        "today",
        "research",
        "paul",
        "matteis",
        "midstage",
        "suspicion",
        "time",
        "executive",
        "ron",
        "cohen",
        "monitoring",
        "cell",
        "assessment",
        "bar",
        "efficacy",
        "use",
        "cory",
        "note",
        "year",
        "class",
        "receptor",
        "motor",
        "disease",
        "juncture",
        "competition",
        "judge",
        "march",
        "market",
        "resubmission",
        "marketing",
        "application",
        "companys",
        "inbrija",
        "midday",
        "reporting",
        "bengaluru",
        "editing",
        "bernard",
        "orr",
        "saumyadeb",
        "chakrabarty"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}